ArticleBMJ open2026
Cohort profile: the Shenzhen Birth Cohort (SZBC) study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Shenzhen Birth Cohort (SZBC) is an ongoing prospective study established to investigate the impact of genetic, environmental and lifestyle factors on maternal health and child development in Shenzhen, a metropolis characterised by rapid economic development and a high density of young migrants.
participantsSince March 2018, pregnant women (≤19 weeks of gestation) have been recruited from Nanshan Maternity & Child Healthcare Hospital of Shenzhen. Follow-up assessments are conducted at up to 20 time points from early pregnancy through delivery and childhood (up to 7 years of age). Extensive health data were collected through standardised questionnaires, physical examinations and biological samples (eg, blood, urine, faeces). FINDINGS TO DATE: As of December 2025, 4208 pregnant women were enrolled, of whom 3962 completed baseline data collection and constituted the baseline cohort; 3150 deliveries had been recorded. Preliminary findings included the following: (1) Maternal lifestyles and adverse birth outcomes: poor sleep quality in early pregnancy was associated with higher risks of small-for-gestational-age (SGA). (2) Maternal health conditions and neurodevelopment: higher pre-pregnancy BMI was associated with developmental delays in offspring, particularly in boys. (3) Environmental exposures and neurodevelopment: prenatal exposure to greenness was associated with higher levels of motor development, whereas postnatal PM₂.₅ exposure (notably nitrate) was associated with increased risks of delayed motor and problem-solving development. FUTURE PLANS: Recruitment is planned to continue through 2028, with enrolled children undergoing regular follow-up through 7 years of age. The current phase of cohort follow-up is expected to be completed in 2035. Future studies will integrate electronic medical records and multi-omics data to examine the combined effects of early-life exposures and explore potential biological pathways related to maternal and child health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.